Medicine
fromwww.theguardian.com
1 week agoExciting' clinical results offer hope for new class of MS therapies
A diabetes drug combined with an antihistamine partially repairs myelin damage in multiple sclerosis, improving nerve function but yielding no noticeable benefit after six months.